Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Aug 21, 2020, 21:50 ET Covalon Announces Conference Call to Discuss Third Quarter Financial Results

MISSISSAUGA, ON, Aug. 21, 2020 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical...


Aug 21, 2020, 16:30 ET PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on August 18, 2020 it approved non-statutory stock options to purchase an aggregate of...


Aug 21, 2020, 16:00 ET Inhibrx Announces Closing of Initial Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Inhibrx, Inc. ("Inhibrx") (Nasdaq: INBX), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic ...


Aug 21, 2020, 13:53 ET Finding Clues to a Successful Immune Response in the T Cells of Recovered COVID-19 Patients

When news about a novel coronavirus switched from a chronicle of its progress in China to headlines about a worldwide COVID-19 pandemic, Gladstone...


Aug 21, 2020, 13:45 ET Global Immunohistochemistry Market (2020 to 2025) - Increasing Demand for Personalized Medicine Presents Opportunities

The "Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer,...


Aug 21, 2020, 13:00 ET Worldwide Flow Cytometry Industry to 2025 - Impact of COVID-19 on the Market

The "Flow Cytometry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...


Aug 21, 2020, 12:48 ET Chesapeake Urology Named First Axonics® Center of Excellence in the U.S.

Three Chesapeake Urology physicians and their teams have been designated as Axonics Centers of Excellence by Axonics Modulation Technologies, Inc....


Aug 21, 2020, 11:16 ET Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2020 Results Presentation and Webcast - correction

Nordic Nanovector ASA (OSE: NANO) announces that it will report its results for the second quarter and first half 2020 on Thursday, 27 August 2020. A ...


Aug 21, 2020, 11:02 ET Northwest Biotherapeutics Announces $5 Million Financing

Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers,...


Aug 21, 2020, 10:57 ET Biotech Company Files Patent Infringement Suit Against RenovoDerm and its Related Companies

Acera Surgical, Inc. ("Acera," St. Louis, Missouri), announced that it has filed a patent infringement suit against RenovoDerm LLC and its related...


Aug 21, 2020, 10:32 ET Azzur Group Growth Continues with New Office in Austin, TX; Appointment of Vice President of Consulting Services

To meet the needs of health and life science developers to start, scale, and sustain their GxP organizations, Azzur Group today announces the...


Aug 21, 2020, 10:12 ET Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2020 Results Presentation and Webcast

A presentation by the Nordic Nanovector's senior management team will take place the same day at 8:30 am CEST at: Thon Hotel Vika Atrium,...


Aug 21, 2020, 10:00 ET New Mucinex® GeoVitalPredictor (GVP) Puts Americans One Step Ahead of Cold and Flu Outbreaks

Knowing where sick will happen is more than half the battle. Mucinex®, a leading cold and flu brand with a fighting spirit, is joining forces with...


Aug 21, 2020, 08:15 ET Kintara Therapeutics Announces Additional $2.4 Million Private Placement Priced At-The-Market

Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) ("Kintara" or the "Company") (Nasdaq: KTRA) announced today that it has entered...


Aug 21, 2020, 08:11 ET Therapix Biosciences Announces Replacement of its Board of Directors

Therapix Biosciences Ltd. (OTC Pink: TRPXY) (the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of...


Aug 21, 2020, 07:04 ET Invitation to presentation of BioInvent's second quarter report 2020 on August 27, 2020

BioInvent International AB (OMXS: BINV) will issue its interim report for the second quarter 2020 on Thursday August 27 at 8.00 a.m. CEST, followed...


Aug 21, 2020, 06:00 ET Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received...


Aug 21, 2020, 05:00 ET Cipla e Stempeutics trabalham em parceria para o lançamento do Stempeucel®, a primeira terapia celular 'feita na Índia' para o tratamento da isquemia crítica de membros (ICM)

A Cipla Limited (BSE: 500087) (NSE: CIPLA EQ), denominada "Cipla", anunciou hoje que sua parceira Stempeutics Research Pvt. Ltd obteve a aprovação...


Aug 21, 2020, 05:00 ET Cipla y Stempeutics colaboran para el lanzamiento de Stempeucel®, primera terapia celular "hecha en India" para el tratamiento de la isquemia crítica de las extremidades (ICE)

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ), conocida como "Cipla", anunció hoy que su socio Stempeutics Research Pvt. Ltd ha recibido la aprobación...


Aug 21, 2020, 00:00 ET Cipla y Stempeutics colaboran para lanzar la terapia celular Stempeucel®

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ), denominada "Cipla", ha anunciado hoy que su socio Stempeutics Research Pvt. Ltd ha recibido la...


Aug 21, 2020, 00:00 ET Cipla und Stempeutics kooperieren bei der Markteinführung von Stempeucel®, der ersten 'Made in India'-Zelltherapie zur Behandlung der kritischen Extremitätenischämie (CLI)

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (nachstehend "Cipla") gab heute bekannt, dass sein Partner Stempeutics Research Pvt. Ltd. die behördliche ...


Aug 21, 2020, 00:00 ET Cipla et Stempeutics collaborent en vue du lancement de Stempeucel®, première thérapie cellulaire « Made in India » visant à traiter l'ischémie critique chronique des membres (ICC)

Cipla Limited (BSE : 500087) (NSE : CIPLA EQ), désignée ici sous le nom de « Cipla », a annoncé aujourd'hui que son partenaire Stempeutics Research...


Aug 20, 2020, 20:03 ET Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results

Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has announced its second quarter financial...


Aug 20, 2020, 16:05 ET Poseida Therapeutics Reports Operational Update and Financial Results for Second Quarter and First Half of 2020

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to ...


Aug 20, 2020, 16:05 ET Cytocom, Inc. Announces Agreement to Reacquire Rights to Lead Drug Candidate CYTO-201 and CYTO-401 in Emerging Markets

Cytocom, Inc. (Cytocom), a clinical-stage biopharmaceutical company developing novel immune modulating therapies based on proprietary platforms,...